Showing results (671-680 of 5,659) with videos related to

Sort By:
Pageof 566
Drug Design, Development and Therapy|August 18, 2017
Efficacy and tolerability of two different formulations of atorvastatin in Korean patients with hypercholesterolemia: a multicenter, prospective, randomized clinical trialJu-Hee Lee, Sang-Hyun Kim, Dong-Ju Choi, et al.
Drug Design, Development and Therapy|August 24, 2017
Modeling the human Nav1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockadeMarawan Ahmed, Horia Jalily Hasani, Aravindhan Ganesan, et al.
Drug Design, Development and Therapy|October 19, 2017
Functional and morphological effects of diazepam and midazolam on tumor vasculature in the 9L gliosarcoma brain tumor model using dynamic susceptibility contrast MRI: a comparative studyNuo Yan, Yuzhen Zheng, Cheng Yang
Drug Design, Development and Therapy|October 26, 2017
Protective effect of DA-9401 in finasteride-induced apoptosis in rat testis: inositol requiring kinase 1 and c-Jun N-terminal kinase pathwayKiran Kumar Soni, Yu Seob Shin, Bo Ram Choi, et al.
Drug Design, Development and Therapy|August 30, 2017
Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapySolomon A Graf, Jose M Garcia
Drug Design, Development and Therapy|May 5, 2016
Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathwayXingcong Ma, Wanjun Yan, Zhijun Dai, et al.
Drug Design, Development and Therapy|September 2, 2017
Pomalidomide in the treatment of multiple myeloma: design, development and place in therapyRafael Ríos-Tamayo, Agustín Martín-García, Carolina Alarcón-Payer, et al.
Drug Design, Development and Therapy|October 17, 2017
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndromeAyşe Elif Özdener, Anastasia Rivkin
Drug Design, Development and Therapy|October 17, 2017
Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trialsManni Wang, Xuelei Ma, Linghong Guo, et al.
Drug Design, Development and Therapy|October 17, 2017
The new era of nanotechnology, an alternative to change cancer treatmentAncuta Jurj, Cornelia Braicu, Laura-Ancuta Pop, et al.
Pageof 566